Home
Sanquin

Sanquin Market Share Analysis for June 2026

Een Sanquin-medewerker heeft alleen toegang tot de gegevens die hij of zij nodig heeft voor het uitvoeren van zijn of haar werkzaamheden.

Health > Medicine

Domainsanquin.org

Year Founded1998

Employees1001 - 5000

Annual Revenue$500M - $1B

Sanquin

Sanquin (including company regionals)

sanquin.org

See more website traffic and engagement information

Sanquin Revenue up to June 2026 is 500M - 1B

revenue generated by Sanquin top domains

Sanquin top domains revenue over 3 years

Revenue for Sanquin top domains

sanquin.org500M - 1B

See more with Sales Intelligence

Total visits to Sanquin's top domains

Understand Sanquin market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

sanquin.org3.4K

See more with Sales Intelligence

Avg. visit duration in Sanquin's top domains

Analyze Sanquin engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

sanquin.org00:00:27

See more with Sales Intelligence

Avg. pageviews on Sanquin's top domains

See how Sanquin keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

sanquin.org1.84

See more with Sales Intelligence

Sanquin top competitors by domain

Top similar sites in June 2026, ranked by their affinity

ifmsa.nlCompany NameIFMSA-NLEmployees1001 - 5000HQNetherlands, AmsterdamAnnual revenue$5M - $10MTotal visits5KHealth > Medicine

Top technologies used by Sanquin

These are the website technologies, by industry, used by Sanquin top domains

Content Management System (3)

WordPress

Conversion & Analytics (3)

Google Analytics

Advertising (2)

DoubleClick

eCommerce (2)

Swap

More Technologies

10

See all

News & Signals from Sanquin

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSanquin group partners with Hubrecht Institute, Developmental Biology and Stem Cell Research.Sanquin, in collaboration with the Hubrecht Institute, has developed several innovative gene therapies for sickle cell disease and beta-thalassemia.

NewsSanquin group sells assets to 819 Capital.819 Capital Partners (819) has acquired Direct Diagnostics from Sanquin Health Solutions (SHS).

NewsSanquin group partners with Essange Reagents.We've leveraged our long collaboration with Essange Reagents, formerly Sanquin Reagents, to deliver the new PyroCell MAT Rapid Systems, offering customers two MAT solutions that are easier to execute.